April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Evaluation of Safety and Efficacy of Photosystem I Proteoliposome Subretinal Injection in Retinal Degenerate Rats
Author Affiliations & Notes
  • Yuntao Hu
    Ophthalmology, Doheny Eye Institute-USC, Los Angeles, California
    Ophthalmology, Peking University Third Hospital, Beijing, China
  • Alejandra Gonzalez
    Ophthalmology, Doheny Eye Institute-USC, Los Angeles, California
  • Laura Liu
    Ophthalmology, Doheny Eye Institute-USC, Los Angeles, California
    Ophthalmology, Chang Gung Memorial Hospital, Linko, Taiwan
  • Barbara R. Evans
    Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee
  • Elias Greenbaum
    Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee
  • Robert Chow
    Physiology and Biophysics, Keck School of Medicine-USC, Los Angeles, California
  • Biju B. Thomas
    Ophthalmology, Doheny Eye Institute-USC, Los Angeles, California
  • Mark S. Humayun
    Ophthalmology, Doheny Eye Institute-USC, Los Angeles, California
  • Footnotes
    Commercial Relationships  Yuntao Hu, None; Alejandra Gonzalez, None; Laura Liu, None; Barbara R. Evans, None; Elias Greenbaum, None; Robert Chow, None; Biju B. Thomas, None; Mark S. Humayun, None
  • Footnotes
    Support  Department of Energy, Alcon Research Award to MSH, NEI EY03040
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 425. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuntao Hu, Alejandra Gonzalez, Laura Liu, Barbara R. Evans, Elias Greenbaum, Robert Chow, Biju B. Thomas, Mark S. Humayun; Evaluation of Safety and Efficacy of Photosystem I Proteoliposome Subretinal Injection in Retinal Degenerate Rats. Invest. Ophthalmol. Vis. Sci. 2011;52(14):425.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Photosystem I (PS-1) is a membrane protein complex that catalyzes sunlight-driven transmembrane electron transfer as part of the photosynthetic process. Previously it was demonstrated that light stimulation led to increase in intracellular calcium concentrations (suggestive of neuronal activation) in retinal ganglion cells following incubation with PS-1 proteoliposomes. The purpose of this study is to assess the morphological and functional changes due to subretinal PS-1 proteoliposome injection in a retinal degenerate rat model, the Royal College of Surgeons (RCS) rats.

Methods: : Dystrophic RCS rats (n=6) without any visual sensitivity ( >6 months old) were used for subretinal injection of PS-1 proteoliposomes (30 µl/eye). The fellow (non-injected) eye served as the control. One week after injection, ophthalmic examinations were performed based on fundus photography. Visual functional evaluations were performed using a computer-based optokinetic instrument equipped with a red filter. All animals were sacrificed at 30 days after injection and both eyes were subjected to histological examination using hematoxylin & eosin staining.

Results: : Based on ophthalmic examinations, no apparent differences were observed between the injected and the control (non-injected) eyes. Safety of PS-1 proteoliposome injections in the rat’s eye was confirmed based on the histological examinations. Optokinetic behavioral assays demonstrated restoration of visual head-tracking response in two rats (2/6) only in the PS-1 injected eye.

Conclusions: : No signs of complications were observed in rats subsequent to subretinal injection of PS-1 proteoliposomes. Restoration of optokinetic head-tracking response in the PS-1 injected eyes suggest that PS-1 proteoliposomes have the potential to be used as a treatment strategy for vision restoration in blind human subjects.

Keywords: degenerations/dystrophies • retina • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×